Financials
Financial year 2025
SYNEOS HEALTH BELGIUM from Brussel, company number BE0812400635, closed financial year 2025 with a result of € 1.9 million after tax. For that financial year SYNEOS HEALTH BELGIUM recorded revenue of € 18.9 million and equity of € 5.7 million. Compared with financial year 2023, the result moved from € 1.6 million to € 1.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 5.7 million
▲ 8% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.9 million
▲ 19% vs 2023
Profit after tax over the fiscal year.
€ 2.2 million
▲ € 1.9 million vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 5.3 million.
People and assets in 2025
116.5
▲ 7.1 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 14.7 million
▲ 12% vs 2023
€ 126,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 26,063
▼ 42% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 461,612
▲ 8% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 53 days on average.
€ 2.1 million
▼ 13% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 19,863,872 | € 18,464,425 | € 18,479,505 | € 18,932,261 | ▲ 2% |
| Profit after taxes | € 1,740,682 | € 1,566,570 | € 1,599,381 | € 1,906,391 | ▲ 19% |
| Equity | € 8,092,194 | € 9,658,764 | € 5,278,782 | € 5,708,917 | ▲ 8% |
| Total debts | € 4,439,969 | € 2,754,343 | € 5,629,369 | € 2,821,795 | ▼ 50% |
| Cash | € 231,001 | € 890,773 | € 290,300 | € 2,178,959 | ▲ € 1.9 million |
| Retained profit | € 7,720,616 | € 9,287,186 | € 4,907,204 | € 5,337,339 | ▲ 9% |
| Dividend | € 0 | € 0 | € 5,979,363 | € 0 | ▼ 100% |
| Bank debt | € 559,383 | € 0 | € 2,497,975 | € 0 | ▼ 100% |
| Balance sheet total | € 12,532,163 | € 12,413,108 | € 10,908,151 | € 8,530,712 | ▼ 22% |
| Employees (FTE) | 113.2 | 112.7 | 109.4 | 116.5 | ▲ 7.1 |
Key figures of SYNEOS HEALTH BELGIUM, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SYNEOS HEALTH BELGIUM?
What happened at SYNEOS HEALTH BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.9 million (▲ 19% vs 2023). Source: NBB ↗
- Christine Lemasson became a director. NBB
- Terttu Haring stepped down as director. NBB
- Terttu Haring became a director. NBB
- Nyla SINGH became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 1.7 million profit in 2021 to € 1.9 million profit in 2025.
Paid € 2.8 million in corporate taxes since 2021.
Best year ever: 2025, with € 1.9 million profit.
Paid out € 6 million in dividends to the owners in total.
A new publication or filing at SYNEOS HEALTH BELGIUM? We notify you, reason included.
Follow SYNEOS HEALTH BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SYNEOS HEALTH BELGIUM are Christine Lemasson and Nyla SINGH.
Directors
According to the 2025 annual accounts
Christine Lemasson
Director
since 2025
Nyla SINGH
Director
since 2020
Terttu Haring
Director
since 2024 · until 2025
Establishments
Establishment units
Physical locations of this company
Louizalaan 287/16
1050 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0812.400.635
- VAT number
- BE 0812.400.635
- Registered office
- Louizalaan 287/16, 1050 Brussel
- Names & denominations
- SYNEOS HEALTH BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 June 2009
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige zakelijke dienstverlening, neg
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria